Advertisement
Research Article| Volume 337, 577070, December 15, 2019

Download started.

Ok

Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis

  • Natalia S. Novikova
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Department of General Pathology and Pathophysiology, FGBNU “Institute of Experimental Medicine”, St. Petersburg, Russian Federation
    Search for articles by this author
  • Anastasia S. Diatlova
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Department of General Pathology and Pathophysiology, FGBNU “Institute of Experimental Medicine”, St. Petersburg, Russian Federation
    Search for articles by this author
  • Kristina Z. Derevtsova
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Department of General Pathology and Pathophysiology, FGBNU “Institute of Experimental Medicine”, St. Petersburg, Russian Federation
    Search for articles by this author
  • Elena A. Korneva
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Department of General Pathology and Pathophysiology, FGBNU “Institute of Experimental Medicine”, St. Petersburg, Russian Federation
    Search for articles by this author
  • Tamara V. Viktorovna
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation
    Search for articles by this author
  • Yuri Ostrinki
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Lital Abraham
    Affiliations
    St George's, University of London MBBS programme at the University of Nicosia Medical school, Cyprus, in Collaboration with Sheba Medical Center, Israel
    Search for articles by this author
  • Shir Quinn
    Affiliations
    Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Yahel Segal
    Affiliations
    Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Leonid P. Churilov
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Department of General Pathology and Pathophysiology, FGBNU “Institute of Experimental Medicine”, St. Petersburg, Russian Federation
    Search for articles by this author
  • Miri Blank
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Yehuda Shoenfeld
    Affiliations
    Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation

    Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Rina Aharoni
    Affiliations
    Department of Immunology, The Weizmann Institute of Science, Rehovot 761001, Israel
    Search for articles by this author
  • Howard Amital
    Correspondence
    Corresponding author: The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 5262100, Israel.
    Affiliations
    Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Internal Medicine B and Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author

      Highlights

      • Tuftsin-phosphorylcholine (TPC) is a novel immune-modulating helminth derived compound.
      • We examine the effects of acute treatment with TPC on experimental autoimmune encephalomyelitis, a murine model of MS.
      • We propose the TPC as a novel treatment for delaying disease progression and preventing exacerbations of MS.

      Abstract

      Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) which carries a significant burden of morbidity and mortality. Herein we examine the effects of acute treatment with tuftsin-phosphorylcholine (TPC), a novel immune-modulating helminth derived compound, on a murine model of MS. Experimental autoimmune encephalomyelitis (EAE) mice received acute treatment with TPC showed an improved clinical score and significantly less signs of inflammation and demyelination in CNS tissue compared with vehicle treated EAE mice. Our findings suggest that TPC may provide a beneficial clinical effect in EAE and may therefore have a potential value for ameliorating clinical manifestations and delaying disease progression in MS.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Neuroimmunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Allen Brain Atlas L
        A Digital Color Brain Atlas of the C57BL/6J male mouse.
        in: Price Joseph L. The Quarterly Review of Biology. 83. 2008: 401-402 (4)
        • Aharoni R.
        Immunomodulation neuroprotection and remyelination – the fundamental therapeutic effects of glatiramer acetate: a critical review.
        J. Autoimmun. 2014; 54: 81-92
        • Aharoni R.
        • Sasson E.
        • Blumenfeld-Katzir T.
        • Eilam R.
        • Sela M.
        • Assaf Y.
        • Arnon R.
        Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
        Exp. Neurol. 2013; 240: 130-144
        • Aharoni R.
        • Rosen C.
        • Shezen E.
        • Bar-Lev D.D.
        • Golani O.
        • Reisner Y.
        • Sela M.
        • Arnon R.
        Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis.
        J. Neuroimmunol. 2016; 301: 7-11
        • Bach J.-F.
        The hygiene hypothesis in autoimmunity: the role of pathogens and commensals.
        Nat. Rev. Immunol. 2017; 18: 105-120
        • Baecher-Allan C.
        • Kaskow B.J.
        • Weiner H.L.
        Multiple sclerosis: mechanisms and immunotherapy.
        Neuron. 2018; 97: 742-768
        • Baker D.
        • Amor S.
        Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis.
        J. Neuroimmunol. 2012; 242: 78-83
        • Bashi T.
        • Bizzaro G.
        • Ben-Ami Shor D.
        • Blank M.
        • Shoenfeld Y.
        The mechanisms behind helminth’s immunomodulation in autoimmunity.
        Autoimmun. Rev. 2015; 14: 98-104
        • Bashi T.
        • Blank M.
        • Ben-Ami Shor D.
        • Fridkin M.
        • Versini M.
        • Gendelman O.
        • Volkov A.
        • Barshak I.
        • Shoenfeld Y.
        Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
        J. Autoimmun. 2015; 59: 1-7
        • Bashi T.
        • Shovman O.
        • Fridkin M.
        • Volkov A.
        • Barshack I.
        • Blank M.
        • Shoenfeld Y.
        Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.
        Clin. Exp. Immunol. 2016; 184: 19-28
        • Ben-Ami Shor D.
        • Harel M.
        • Eliakim R.
        • Shoenfeld Y.
        The hygiene theory harnessing helminths and their ova to treat autoimmunity.
        Clin. Rev. Allergy Immunol. 2013; 45: 211-216
        • Ben-Ami Shor D.
        • Bashi T.
        • Lachnish J.
        • Fridkin M.
        • Bizzaro G.
        • Barshak I.
        • Blank M.
        • Shoenfeld Y.
        Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
        J. Autoimmun. 2015; 56: 111-117
        • Ben-Amram H.
        • Bashi T.
        • Werbner N.
        • Neuman H.
        • Fridkin M.
        • Blank M.
        • Shoenfeld Y.
        • Koren O.
        Tuftsin-phosphorylcholine maintains normal gut microbiota in collagen induced arthritic mice.
        Front. Microbiol. 2017; 8: 1222-1229
        • Bhasin M.
        • Wu M.
        • Tsirka S.E.
        Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
        BMC Immunol. 2007; 8: 10-26
        • Blank M.
        • Bashi T.
        • Lachnish J.
        • Ben-Ami-Shor D.
        • Shovman O.
        • Fridkin M.
        • Eisenstein M.
        • Volkov A.
        • Barshack I.
        • Shoenfeld Y.
        Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis.
        PLoS One. 2018; 13 (e0200615): 1-17
        • Bourne J.A.
        Handbook of Immunoperoxidase Staining Methods.
        (Publ. 1983) Dako, St. Barbar1983
        • Cabre P.
        • Signate A.
        • Olindo S.
        • Merle H.
        • Caparros-Lefebvre D.
        • Béra O.
        • Smadja D.
        Role of return migration in the emergence of multiple sclerosis in the French West Indies.
        Brain. 2005; 128: 2899-2910
        • Chauhan A.
        • Quenum F.Z.
        • Abbas A.
        • Bradley D.S.
        • Nechaev S.
        • Singh B.B.
        • Sharma J.
        • Mishra B.B.
        Epigenetic modulation of microglial inflammatory gene loci in helminth-induced immune suppression.
        ASN Neuro. 2015; 7: 1-12
        • Compston A.
        • Coles A.
        Multiple sclerosis.
        Lancet. 2008; 372: 1502-1517
        • Cooke A.
        Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?.
        Immunology. 2009; 126: 12-17
        • Correale J.
        • Farez M.
        Association between parasite infection and immune responses in multiple sclerosis.
        Ann. Neurol. 2007; 61: 97-108
        • Correale J.
        • Farez M.F.
        The impact of environmental infections (parasites) on MS activity.
        Mult. Scler. J. 2011; 17: 1162-1169
        • Correale J.
        • Farez M.F.
        The impact of parasite infections on the course of multiple sclerosis.
        J. Neuroimmunol. 2011; 233: 6-11
        • Dixit A.
        • Tanaka A.
        • Greer J.M.
        • Donnelly S.
        Novel therapeutics for multiple sclerosis designed by parasitic worms.
        Int. J. Mol. Sci. 2017; 18: 2141-2158
        • Fleming J.O.
        • Cook T.D.
        Multiple sclerosis and the hygiene hypothesis.
        Neurology. 2006; 67: 2085-2086
        • Fleming J.O.
        • Isaak A.
        • Lee J.E.
        • Luzzio C.C.
        • Carrithers M.D.
        • Cook T.D.
        • Field A.S.
        • Boland J.
        • Fabry Z.
        Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.
        Mult. Scler. 2011; 17: 743-754
        • Fleming J.
        • Hernandez G.
        • Hartman L.
        • Maksimovic J.
        • Nace S.
        • Lawler B.
        • Risa T.
        • Cook T.
        • Agni R.
        • Reichelderfer M.
        • Luzzio C.
        • Rolak L.
        • Field A.
        • Fabry Z.
        Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: results of the HINT 2 clinical trial.
        Mult. Scler. J. 2017; 81–91
        • Gause W.C.
        • Urban J.F.
        • Stadecker M.J.
        The immune response to parasitic helminths: insights from murine models.
        Trends Immunol. 2003; 24: 269-277
        • Goodridge H.S.
        • McGuiness S.
        • Houston K.M.
        • Egan C.A.
        • AL-Riyami L.
        • Alcocer M.J.C.
        • Harnett M.M.
        • Harnett W.
        Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells.
        Parasite Immunol. 2007; 29: 127-137
        • Lassmann H.
        Mechanisms of inflammation induced tissue injury in multiple sclerosis.
        J. Neurol. Sci. 2008; 274: 45-47
        • Li J.
        • Chen Y.
        • Chen Z.
        • Huang Y.
        • Yang D.
        • Su Z.
        • Weng Y.
        • Li X.
        • Zhang X.
        Therapeutic effects of human adipose tissue-derived stem cell (hADSC) transplantation on experimental autoimmune encephalomyelitis (EAE) mice.
        Sci. Rep. 2017; 7: 42695-42705
        • Nair A.
        • Frederick T.J.
        • Miller S.D.
        Astrocytes in multiple sclerosis: a product of their environment.
        Cell. Mol. Life Sci. 2008; 65: 2702-2720
        • Najjar and Nishioka
        • Najjar V.A.
        • Nishioka K.
        “Tuftsin”: a natural phagocytosis stimulating peptide.
        Nature. 1970; 228: 672-673
        • Nissen J.C.
        • Tsirka S.E.
        Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.
        Glia. 2016; 64: 923-936
        • Pineda M.A.
        • Lumb F.
        • Harnett M.M.
        • Harnett W.
        ES-62, a therapeutic anti-inflammatory agent evolved by the filarial nematode Acanthocheilonema viteae.
        Mol. Biochem. Parasitol. 2014; 194: 1-8
        • Redpath S.A.
        • Fonseca N.M.
        • Perona-Wright G.
        Protection and pathology during parasite infection: IL-10 strikes the balance.
        Parasite Immunol. 2014; 36: 233-252
        • Shemer A.
        • Kivity S.
        • Shovman O.
        • Bashi T.
        • Perry O.
        • Watad A.
        • Ben-Ami Shor D.
        • Volkov A.
        • Barshack I.
        • Bragazzi N.L.
        • Krule A.
        • Fridkin M.
        • Amital H.
        • Blank M.
        • Shoenfeld Y.
        Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
        Clin. Exp. Immunol. 2018; 193: 160-166
        • Siebert A.
        • Gensicka-Kowalewska M.
        • Cholewinski G.
        • Dzierzbicka K.
        Tuftsin – properties and analogs.
        Curr. Med. Chem. 2017; 24: 3711-3727
        • Siemion I.Z.
        • Kluczyk A.
        Tuftsin: on the 30-year anniversary of victor Najjar’s discovery.
        Peptides. 1999; 20: 645-674
        • Sotgiu S.
        • Angius A.
        • Embry A.
        • Rosati G.
        • Musumeci S.
        Hygiene hypothesis: innate immunity, malaria and multiple sclerosis.
        Med. Hypotheses. 2008; 70: 819-825
        • Steinman L.
        Immunology of relapse and remission in multiple sclerosis.
        Annu. Rev. Immunol. 2014; 32: 257-281
        • Thompson A.J.
        • Baranzini S.E.
        • Geurts J.
        • Hemmer B.
        • Ciccarelli O.
        Multiple sclerosis.
        Lancet. 2018; 391: 1622-1636
        • Versini M.
        • Jeandel P.-Y.
        • Bashi T.
        • Bizzaro G.
        • Blank M.
        • Shoenfeld Y.
        Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.
        BMC Med. 2015; 13: 81-97

      Linked Article